Zydus Lifesciences receives USFDA observations for injectable facilityZYDUSLIFE - 357 Change: 18.10 (5.34 %)
News: Zydus Lifesciences' injectable facility at Jarod, Gujarat underwent a USFDA inspection from February 24 to March 10, 2022. The inspection closed with three observations from USFDA.
Views: The injectable facility at Jarod, Gujarat is a critical site for the US injectable business amid existing warning letter for Moraiya facility. Zydus aims to create a US$250 million plus franchise on injectable front in three years. However, with both Moraiya and Jarod facility under regulatory non-compliance, key launches of transmerdal portfolio and complex injectables is likely to get affected.